Form TA-1/A BNY Mellon International
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20250609/ABZ2N22CZ22252X2222P22Z2MNUT8S2S7272
Filed on: June 3, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PrimeBOT Wins Gold and Silver at A' Design Award 2026 -- A New Language for Personal Robotics
- Lemonade To Announce Second Quarter 2026 Financial Results
- Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
